Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1612-1617

  Cao, Liping ^a   Duchrow, M ^a   Windhovel U ^a   Kujath, P ^b   Bruch, H P ^b   Broll, R ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Gall bladder cancer; MDR; P glycoprotein; Paraffin embedded tissue

Indexed keywords

FORMALDEHYDE; GLYCOPROTEIN P; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANTIGEN RECOGNITION; ARTICLE; CANCER STAGING; CROSS RESISTANCE; GALLBLADDER CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; FEMALE; GALLBLADDER NEOPLASMS; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0032167888     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00142-7     Document Type: Article

References (32)

1. 1. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinoma of the gall bladder. Results of French Surgical Association survey. Ann Surg 1994, 219, 275-280.
2. 2. Gall FP, Kockerling F, Scheele J, Schneider C, Hohenberger W. Radical operation for carcinoma of gall bladder: present status in Germany. World J Surg 1991, 15, 328-336.
3. 3. Siewert R, Cassau D. Das Gallenblasenkarzinom. Bericht über 120 eigene Beobachtungen. Dtsch Med Wschr 1968, 19, 223-231.
4. 4. Ouchi K, Suzuki M, Saijo S, Ito K, Matsuno S. Do recent advances in diagnosis and operative management improve the outcome of gall bladder carcinoma?. Surgery 1993, 113, 324-329.
5. 5. Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gall bladder according to the TNM stage. Surgery 1996, 120, 816-821.
6. 6. Pradeep R, Kaushik SP, Sikora SS, Bhattacharya BN, Pandey CM, Kapoor VK. Predictors of survival in patients with carcinoma of the gall bladder. Cancer 1995, 76, 1145-1149.
7. 7. Roninson IB, Chin JE, Choi KG, et al. Isolation of human MDR DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 1986, 83, 4538-4542.
8. 8. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976, 455, 152-162.
9. 9. Kalken CK van, Pinedo HM, Gieccone G. Multidrug resistance of the clinical point of view. Eur J Cancer 1991, 27, 1481-1486.
10. 10. Bradley G, Ling V. P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev 1994, 13, 223-233.
11. 11. Willman CL. Immunophenotyping and cytogenetics in older adults with acute myeloid leukemia: significance of expression of the multidrug resistance gene-1 (MDR1). Leukemia 1996, 10(Suppl. 1), S33-S35.
12. 12. Botti G, Chiappetta G, D'Aiuto G, et al. PCNA/cyclin and P-glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective study. Tumori 1993, 79, 214-218.
13. 13. Hermanek P, Sobin LH (eds). UICC: TNM Classification of Malignant Tumours, 4th edition, 2nd revision. Berlin, Springer, 1995.
14. 14. Shen DW, Fojo A, Chin JE, et al. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 1986, 232, 643-645.
15. 15. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987, 84, 265-269.
16. 16. Scheper RJ, Bulte JW, Brakkee JG, et al. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer 1988, 42, 389-394.
17. 17. Schinkel AH, Arceci RJ, Smit JJ, et al. Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P-glycoprotein. Int J Cancer 1993, 55, 478-484.
18. 18. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32, 219-229.
19. 19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium, thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162, 156-159.
20. 20. Martin RK, Archer KT, Tuttle RM. Detection of ptc in archival formalin-fixed, paraffin-embedded tissues. Comparison of radiolabeled DNA hybridization and direct incorporation of digoxigenin-11-dUTP into RT-PCR products. Diagn Mol Pathol 1994, 3, 233-239.
21. 21. Yamaguchi M, Dieffienbach CW, Connolly R, Cruess DF, Baur W, Sharefkin JB. Effect of different laboratory techniques for guanidinium-phenol-chloroform RNA extraction on A260/A280 and on accuracy of mRNA quantitation by reverse transcriptase-PCR. PCR Methods Appl 1992, 1, 286-290.
22. 22. Hilton DA, Variend S, Pringle JH. Demonstration of Coxsackie virus RNA in formalin-fixed tissue sections from childhood myocarditis cases by in situ hybridization and the polymerase chain reaction. J Pathol 1993, 170, 45-51.
23. 23. O'Driscoll L, Kennedy S, McDermott E, Kelehan P, Clynes M. Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue. Eur J Cancer 1996, 32A, 128-133.
24. 24. Taylor JJ, Heasman PA. Control genes for reverse transcriptase/ polymerase chain reaction (RT-PCR). Br J Haematol 1994, 86, 444-445.
25. 25. Mies C. A simple, rapid method for isolating RNA from paraffin-embedded tissues for reverse transcription-polymerase chain reaction (RT-PCR). J Histochem Cytochem 1994, 42, 811-813.
26. 26. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan MM, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987, 84, 7735-7738.
27. 27. Gottesman MM, Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem 1988, 263, 12163-12166.
28. 28. Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, Gottesman MM. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 1987, 236, 1120-1122.
29. 29. Biedler JL. Genetic aspects of multidrug resistance. Cancer 1992, 70(6 Suppl.), 1799-1809.
30. 30. Pavelic ZP, Reising J, Pavelic L, Kelley DJ, Stambrook PJ, Gluckman JL. Detection of P-glycoprotein with four monoclonal antibodies in normal and tumor tissues. Arch Otolaryngol Head Neck Surg 1993, 19, 753-757.
31. 31. Fairchild CR, Ivy SP, Rushmore T, et al. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci USA 1987, 84, 7701-7705.
32. 32. Beck WT, Grogan TM, Willman CL, et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumours: consensus recommendations. Cancer Res 1996, 56, 3010-3020.